Publication

Epidemiological and biochemical aspects of progression in multiple sclerosis

Koch, M. W., 2008, s.n.. 203 p.

Research output: ThesisThesis fully internal (DIV)Academic

  • Marcus Werner Koch
Patients with a progressive form of multiple sclerosis have the worst prognosis. They can expect that their symptoms will steadily worsen, and there is currently no treatment that has a proven effect on progressive multiple sclerosis. The underlying pathophysiology of the progressive forms of multiple sclerosis appears to be distinct from that of the relapsing-remitting form. Research on multiple sclerosis has largely been focussed on the relapsing-remitting form of the disease, while there is relatively little knowledge of the progressive forms of MS. In this thesis, we aimed to investigate epidemiological and biochemical factors associated with progression in MS.
Original languageEnglish
QualificationDoctor of Philosophy
Supervisors/Advisors
  • de Keyser, Jacques, Supervisor
Publisher
Print ISBNs9789036732871
Publication statusPublished - 2008

    Keywords

  • Multiple sclerose, Epidemiologie , Biochemie Proefschriften, neurologie

View graph of relations

ID: 14592926